Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Cali Biosciences Presents Phase IIa Clinical Data on CPL-01, a Long-Acting Ropivacaine

prnasiaNovember 19, 2021

Tag: Cali Biosciences , CPL-01 , Ropivacaine

PharmaSources Customer Service